For Patients

Simplifying access to comprehensive UTI care

Biotia, in partnership with Clinova Solutions, has created a full service care pathway for patients managing challenging UTIs.

What it is

At-home UTI testing and treatment

The standard of care for UTI patients is flawed. The tests most providers use miss important pathogens. Clinical expertise in diagnosing and treating patients with complex UTI histories is difficult to find. For many patients navigating challenging UTIs, the prospect of finding relief can feel bleak.

Advanced, at-home diagnostic testing

Telehealth from UTI specialists

Treatment and follow-up care made easy

Advanced, at-home diagnostic testing

Telehealth from UTI specialists

Treatment and follow-up care made easy

BIOTIA-ID Urine

Built for challenging UTI cases

The BIOTIA-ID Urine Test is a clinical metagenomic-based diagnostic test that outperforms standard urine culture. It is available for at-home collection across all 50 U.S. states.

Highlights

Identifies 44 pathogens, including bacteria and fungi
Detects pathogens often missed by standard urine culture
Drug resistance profiling included to guide targeted treatment

What is clinical metagenomics

See how next-generation sequencing is changing the way urinary tract infections are diagnosed and treated.

Learn more

Comparison

The BIOTIA‑ID Urine Test

View pathogens

The BIOTIA-ID Urine Test outperforms standard urine culture and offers enhanced insights as compared to other next-generation sequencing (NGS)-based testing options.

View pathogens

BIOTIA-ID Urine

Clinical metagenomics

16s sequencing

Standard urine culture

Results turnaround

2–3 business days

2–5 business days

Price

$249

$259

Varies

Resolution and detail

Detailed — species or strain level resolution

Poor — genus or species, with some groups unresolved

Detailed — genus or species for species that grow

Kinds of microbes

Extensive — bacteria, fungi, anaerobes, fastidious, and atypical pathogens

Limited — bacteria only

Limited — common bacteria and fungi only

Accuracy

High — limited contamination and false positives

Low — high potential for contamination and false positives

Low — high potential for contamination and false negatives

Percent of genome considered

Extensive — thousands of genes across the entire genome

Low — looks at only one gene in a section of the genome

None, not applicable

Future biomarker and therapeutic insights

High

Low

None

Antimicrobial resistance prediction

High — clinically validated resistance reporting

None

Separate testing required

Clinical relevance

High — healthy microbes filtered from report

Low — reports non-pathogenic species

Low — misses pathogenic species

Evidence

Science you can trust

High accuracy for a breadth of pathogens

Performance

The BIOTIA-ID Urine Test has been extensively validated on clinical samples. It was validated to reliably detect 44 key UTI-causing pathogens and 16 drug resistance markers.

Sensitivity

Specificity

0Pathogens detected

0Drug-resistance markers

The Diagnostic Gap

A negative urine culture does not mean there is nothing there

In a retrospective study of 200+ symptomatic UTI patient samples that were negative by standard urine culture, the BIOTIA-ID Urine Test identified a causative pathogen in a majority of samples.

of culture-negative samples had a pathogen detected by our test

Pathogen detectedNone detected

Knowing the pathogen changes the prescription

The Treatment Gap

Among the patients with a pathogen detected by the BIOTIA-ID Urine Test, the empiric antibiotic chosen under standard care would not have worked in over two out of three cases.

of empiric prescriptions could have been improved

of prescriptions would have had no effect on the pathogen found

could have been de-escalated to a narrower-spectrum drug

Our telehealth partner